223 related articles for article (PubMed ID: 10600481)
1. Localization of glycosaminoglycan substitution sites on domain V of mouse perlecan.
Tapanadechopone P; Hassell JR; Rigatti B; Couchman JR
Biochem Biophys Res Commun; 1999 Nov; 265(3):680-90. PubMed ID: 10600481
[TBL] [Abstract][Full Text] [Related]
2. Formation of heparan sulfate or chondroitin/dermatan sulfate on recombinant domain I of mouse perlecan expressed in Chinese hamster ovary cells.
Kokenyesi R; Silbert JE
Biochem Biophys Res Commun; 1995 Jun; 211(1):262-7. PubMed ID: 7779094
[TBL] [Abstract][Full Text] [Related]
3. Structural basis of glycosaminoglycan modification and of heterotypic interactions of perlecan domain V.
Friedrich MV; Göhring W; Mörgelin M; Brancaccio A; David G; Timpl R
J Mol Biol; 1999 Nov; 294(1):259-70. PubMed ID: 10556044
[TBL] [Abstract][Full Text] [Related]
4. Expression of human perlecan domain I as a recombinant heparan sulfate proteoglycan with 20-kDa glycosaminoglycan chains.
Graham LD; Whitelock JM; Underwood PA
Biochem Biophys Res Commun; 1999 Mar; 256(3):542-8. PubMed ID: 10080934
[TBL] [Abstract][Full Text] [Related]
5. Identification of sites in domain I of perlecan that regulate heparan sulfate synthesis.
Dolan M; Horchar T; Rigatti B; Hassell JR
J Biol Chem; 1997 Feb; 272(7):4316-22. PubMed ID: 9020150
[TBL] [Abstract][Full Text] [Related]
6. Repetitive Ser-Gly sequences enhance heparan sulfate assembly in proteoglycans.
Zhang L; David G; Esko JD
J Biol Chem; 1995 Nov; 270(45):27127-35. PubMed ID: 7592967
[TBL] [Abstract][Full Text] [Related]
7. Perlecan is responsible for thrombospondin 1 binding on the cell surface of cultured porcine endothelial cells.
Vischer P; Feitsma K; Schön P; Völker W
Eur J Cell Biol; 1997 Aug; 73(4):332-43. PubMed ID: 9270876
[TBL] [Abstract][Full Text] [Related]
8. The C-terminal domain V of perlecan promotes beta1 integrin-mediated cell adhesion, binds heparin, nidogen and fibulin-2 and can be modified by glycosaminoglycans.
Brown JC; Sasaki T; Göhring W; Yamada Y; Timpl R
Eur J Biochem; 1997 Nov; 250(1):39-46. PubMed ID: 9431988
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of glycosaminoglycan modification of perlecan domain I by site-directed mutagenesis changes protease sensitivity and laminin-1 binding activity.
Sasaki T; Costell M; Mann K; Timpl R
FEBS Lett; 1998 Sep; 435(2-3):169-72. PubMed ID: 9762901
[TBL] [Abstract][Full Text] [Related]
10. Characterization of recombinant perlecan domain I and its substitution by glycosaminoglycans and oligosaccharides.
Costell M; Mann K; Yamada Y; Timpl R
Eur J Biochem; 1997 Jan; 243(1-2):115-21. PubMed ID: 9030729
[TBL] [Abstract][Full Text] [Related]
11. Perlecan domain V of Drosophila melanogaster. Sequence, recombinant analysis and tissue expression.
Friedrich MV; Schneider M; Timpl R; Baumgartner S
Eur J Biochem; 2000 Jun; 267(11):3149-59. PubMed ID: 10824099
[TBL] [Abstract][Full Text] [Related]
12. Core protein structure and sequence determine the site and presence of heparan sulfate and chondroitin sulfate on syndecan-1.
Kokenyesi R; Bernfield M
J Biol Chem; 1994 Apr; 269(16):12304-9. PubMed ID: 8163535
[TBL] [Abstract][Full Text] [Related]
13. Non-glycosaminoglycan bearing domains of perlecan and aggrecan influence the utilization of sites for heparan and chondroitin sulfate synthesis.
Doege K; Chen X; Cornuet PK; Hassell J
Matrix Biol; 1997 Oct; 16(4):211-21. PubMed ID: 9402011
[TBL] [Abstract][Full Text] [Related]
14. Decorin inhibits cell attachment to thrombospondin-1 by binding to a KKTR-dependent cell adhesive site present within the N-terminal domain of thrombospondin-1.
Merle B; Malaval L; Lawler J; Delmas P; Clezardin P
J Cell Biochem; 1997 Oct; 67(1):75-83. PubMed ID: 9328841
[TBL] [Abstract][Full Text] [Related]
15. Chondrogenic activity of the heparan sulfate proteoglycan perlecan maps to the N-terminal domain I.
French MM; Gomes RR; Timpl R; Höök M; Czymmek K; Farach-Carson MC; Carson DD
J Bone Miner Res; 2002 Jan; 17(1):48-55. PubMed ID: 11771669
[TBL] [Abstract][Full Text] [Related]
16. ZG16p, an animal homolog of β-prism fold plant lectins, interacts with heparan sulfate proteoglycans in pancreatic zymogen granules.
Kumazawa-Inoue K; Mimura T; Hosokawa-Tamiya S; Nakano Y; Dohmae N; Kinoshita-Toyoda A; Toyoda H; Kojima-Aikawa K
Glycobiology; 2012 Feb; 22(2):258-66. PubMed ID: 21948871
[TBL] [Abstract][Full Text] [Related]
17. The complete sequence of perlecan, a basement membrane heparan sulfate proteoglycan, reveals extensive similarity with laminin A chain, low density lipoprotein-receptor, and the neural cell adhesion molecule.
Noonan DM; Fulle A; Valente P; Cai S; Horigan E; Sasaki M; Yamada Y; Hassell JR
J Biol Chem; 1991 Dec; 266(34):22939-47. PubMed ID: 1744087
[TBL] [Abstract][Full Text] [Related]
18. Expression and characterization of minican, a recombinant syndecan-1 with extensively truncated core protein.
Viklund L; Loo BM; Hermonen J; El-Darwish K; Jalkanen M; Salmivirta M
Biochem Biophys Res Commun; 2002 Jan; 290(1):146-52. PubMed ID: 11779146
[TBL] [Abstract][Full Text] [Related]
19. Perlecan in the basement membrane of corneal epithelium serves as a site for P. aeruginosa binding.
Chen LD; Hazlett LD
Curr Eye Res; 2000 Apr; 20(4):260-7. PubMed ID: 10806439
[TBL] [Abstract][Full Text] [Related]
20. Different usage of the glycosaminoglycan attachment sites of biglycan.
Kresse H; Seidler DG; Muller M; Breuer E; Hausser H; Roughley PJ; Schonherr E
J Biol Chem; 2001 Apr; 276(16):13411-6. PubMed ID: 11145959
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
